Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. CCNYL1 Rabbit anti-Human, Polyclonal, Proteintech 

CCNYL1 Rabbit anti-Human, Polyclonal, Proteintech
SDP

Catalog No. 501735519 Shop All Proteintech Group Inc Products
Encompass_Preferred
Change view
Click to view available options
Quantity:
150 μL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
50-173-5519 150 μL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. 50-173-5519 Supplier Proteintech Group Inc Supplier No. 269701AP150UL
Add to Cart
Add to Cart

Description

Rabbit Polyclonal Antibody

CCNYL1 belongs to the cyclin family, Cyclin Y subfamily and contains 1 cyclin N terminal domain. The specific function of CCNYL1 is not yet known.

Specifications

Antigen CCNYL1
Applications Western Blot
Classification Polyclonal
Concentration 0.43 mg/mL
Conjugate Unconjugated
Formulation PBS with 50% glycerol and 0.1% sodium azide; pH 7.3
Gene CCNYL1
Gene Accession No. Q8N7R7
Gene Alias CCNYL1, cyclin Y like 1, Cyclin Y like protein 1
Gene Symbols CCNYL1
Host Species Rabbit
Immunogen CCNYL1 Fusion Protein Ag25583
Purification Method Antigen Affinity Chromatography
Quantity 150 μL
Regulatory Status RUO
Primary or Secondary Primary
Gene ID (Entrez) 151195
Target Species Human
Content And Storage -20°C
Product Type Antibody
Form Liquid
Isotype IgG
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.